Sunday, 22 May 2011

Diabetics are put at risk as NHS cuts hit specialist nursing posts | Society | The Observer

NHS cost-cutting will lead to more diabetic patients having limbs amputated, losing their sight and suffering worsening health, ministers have been warned.

The number of diabetic specialist nurse (DSN) posts unfilled across the service has doubled within a year. A survey of 385 hospital trusts and primary care trusts (PCTs) by Diabetes UK found that 218 jobs were vacant last year, even though the number of people with diabetes is rising by 150,000 a year.

"At a time when numbers of people with diabetes are increasing, a decrease in the number of diabetes specialist nurses is very concerning," said the charity's chief executive, Barbara Young. "This will mean longer waiting times for specialist support, more unnecessary amputations, more people losing their sight and far poorer health outcomes. This is simply not acceptable."

The research also reveals that the proportion of DSN posts lying unfilled because of cost-saving programmes had risen to 43% – up from 34% in 2009. PCTs and hospitals in England have increasingly been reducing their staff and cutting back on the services they provide as they struggle with the demands of a £20bn NHS efficiency drive, flat budgets and rising costs. The new findings confirm a growing tendency among bosses of cash-strapped NHS organisations not to replace specialist nurses – who also help patients with cancer, multiple sclerosis, Parkinson's disease and other conditions – when they retire, move on or are made redundant. However, these nurses are popular with patients and their families, have a proven record of clinical success and an ability to save the NHS money by helping patients stay at home rather than in hospital.

A recent Royal College of Nursing (RCN) survey of almost 800 specialist nurses found 11% said they were at risk of being made redundant because their employers are having to slash budgets.

The loss of DSNs comes despite the number of diabetics having hit a record of 2.8 million. The disease, which can lead to serious complications such as heart problems or disability, is a huge burden on the NHS.

"Diabetes costs the NHS £9bn a year and that can only increase as a result of these short-sighted and harmful actions," said Young. Diabetics account for 15% of all inpatients.

DSNs work in hospitals or in communities. They play a vital role in helping diabetics manage their condition and remain independent. "DSNs face a severe threat to their workforce in the current NHS climate. There is a clear need for specialist support," added Young.

Ministers signalled their displeasure at cuts which they believe should not be happening. "There is no excuse to cut back on services that patients depend on. It is for local trusts to determine their specific workforce needs, but we have made it clear that any reduction in clinical posts must not have an adverse impact on the quality and safety of patient care. Specialist nurses do a fantastic job and are integral to the future of the NHS," said a spokesman for the Department of Health. But he added that the NHS did need to become more efficient in order to meet the growing demand for healthcare.

"It really is worrying that, despite repeated warnings, NHS trusts are still making short-sighted decisions which risk leaving patients high and dry," said Dr Peter Carter, the RCN's chief executive and general secretary. "Our survey showed that more than one in 10 specialist nurses may already be at risk of redundancy, something which we know would have a serious impact on patient care. Not only does this put patients at risk of needless complications, but by doing so it wastes money. The smart solution for trusts would be to keep investing in specialist services which can keep patients as well as possible and, above all, out of hospital."

One in five of Britain's 1,363 DSNs is due to retire by 2016, the Diabetes UK survey found. Young has written to the health secretary, Andrew Lansley, asking him to take trusts to task if they cut or freeze DSN posts.

Word of the Day | Definition, Word Origins, and Quotes at Dictionary.com

Word of the Day

Thursday, January 23, 2003

lackadaisical

\lack-uh-DAY-zih-kuhl\ , adjective;

1.
Lacking spirit or liveliness; showing lack of interest; languid; listless.
Quotes:
Drowsy from the heat and from fatigue, he dozed to the steady lackadaisical clips of the mule's shoes.
-- Patricia Powell, The Pagoda
There was an oddly lackadaisical inflection to his speech. A sense of merely going though the motions.
-- Lesley Hazleton, Driving To Detroit
The very title, Hours of Idleness, which the young lord affixed to his maiden volume, sufficiently indicated the lackadaisical spirit in which he came before the public.
-- J. F. A. Pyre, "Byron in Our Day", The Atlantic, April 1907
The simple fact is, whether we admit it or not, there's never been an "intelligence" or "achievement" test on which the smart and industrious have not done better than the dumb and the lackadaisical.
-- Jonah Goldberg, "Stupid Aptitude Test", National Review, July 1, 2002
Origin:
Lackadaisical comes from the expression lackadaisy, a variation of lackaday, itself a shortening of "alack the (or a) day!"
POWERED BY 4INFO

Saturday, 21 May 2011

Pronexus - interactIVResponse Blog

Blog Posts

Interesting thoughts and ideas on Interactive Voice Response (IVR) and computer telephony. Join the conversation!

If you have topic suggestions, please forward them to marketing@pronexus.com.



  • Blog • April 28, 2011

    Customer Application Spotlight: Vocantas’ Utilities OnCall0

    Pronexus recently sat down with one of our customers, Vocantas, to talk about their utilities IVR application built with VBVoice, Utilities OnCall.

    Read More

  • Blog • April 25, 2011

    Save money with self-service IVR applications0

    Self-service IVR technology allows users who are seeking assistance or information to automatically obtain this assistance without the need of human operators. Self-service provides customer assistance 24 hours a day, 7 days a week. Businesses often look to IVR self-service as a way to offload many mundane, repetitive tasks that otherwise fall to their staff. The business benefit of this approach is that the business can handle more calls with fewer representatives, saving scarce resources for more challenging and higher-value tasks.

    Read More

  • Blog • March 14, 2011

    IVR in Municipal Government0

    In my last blog post, I talked about how banks and financial institutions can greatly benefit from IVR technology. Another industry that has begun to utilize IVR to communicate with their residents is Municipal Government. Municipal Government organizations, including City Hall and courts, are realizing the benefits of automating some of their services.

    Read More

New Research Into Cannabis And Mental Health | CLEAR

Will Gibson, University Of Reading

Will Gibson is studying psychology at the University of Reading.  He is researching the neurological effects of cannabis consumption under the supervision of Dr Ben Whalley, Dr Claire Williams and Dr Gary Stephens.

Cannabinoids And Mental Health – A Fresh Perspective

Whilst the national media repeatedly warn about the dangers of cannabis consumption, particularly to those with pre-existing mental illness, a large number of patients with mental health issues continue to smoke the substance for recreation as well as a form of self-medication. Despite many negative presentations of cannabis in the British media, the worldwide scientific community and pharmaceutical industry are beginning to take a serious interest in the development of medicines based on the psychoactive chemicals, known as cannabinoids, contained in the plant.

The importance of good mental health is steadily increasing as a public priority; this is being reflected in an increase in prescriptions for modern anti-depressants, in particular selective serotonin re-uptake inhibitors (SSRIs).  Recent figures from Primary Care Trusts (PCT) show the number of prescriptions for products like SSRIs  have been increasing progressively since their release on the market.

Several suggestions have been made to explain this  increase, including reports from the BBC that it may be due to the economic recession: http://www.bbc.co.uk/news/health-12986314

An article from Moore et al (2010) in the British Medical Journal (BMJ) reports an increase in the numbers of prescriptions for SSRIs. It highlights the fact that many of the patients receiving a prescription for SSRI’s were doing so as part of the treatment programme for pre-existing mental health conditions and argues therefore that these figures are more of reflection in a shift of prescribing behaviour as opposed to an increase in the prevalence of mental illness.

It is increasingly common for prescribers to provide patients with SSRIs and other anti-depressant medications such bupropion hydrochloride for conditions other than their traditional indications. Such indications include; stopping smoking, anorexia, anxiety disorders, personality disorders as well as post-traumatic stress disorder (PTSD) and hormonal problems.

Regardless of whether there has been an increase in the actual prevalence of affective disorders such as depression it is clear that mental illness has a significant impact on society. The mental health charity “Mind” reports that at any one time 1 in 4 people in the UK will be suffering from a mental health condition. One in six people currently employed in the UK are suffering from depression and the impact on the economy is estimated at£26 billion per annum (Mind.org 2011).

Prescriptions for antidepressants, anxiolytics (anti-anxiety medications) and hypnotics (used for sleep disorders) are extremely costly to the tax payer. (Ref PCTs and NHS/NDFS) Furthermore, despite overwhelming support for the effectiveness of SSRIs from British prescribers the effectiveness of these drugs is a matter of continuous debate. Fournier et al (2010) conducted a meta-analysis of data collected from previous studies into these medicines and found that with mild depression scores many SSRIs are only moderately more effective than placebos.

So could cannabis and/or individual cannabinoids offer a more effective alternative?

Neuroscientists at the University of Reading have been studying the potential medical uses of cannabinoids for nearly a decade.  So far this research has mainly focused on the therapeutic benefits of cannabinoids for patients suffering from epilepsy and eating disorders.  However, plans have now been approved to research the psychological effects of various isolated cannabinoids.  GW Pharmaceuticals, which will be supplying the research materials, already has established specialist research centres dedicated to breeding cannabis plants to contain artificially high levels of certain cannabinoids and our lab will be examining the psychological effects of specific cannabinoids. Whilst there is a wealth of research into the psychological effects of the cannabis plant as a whole, we feel there is not enough information on the effect of individual cannabinoids.

Dr Ben Whalley, Dr Claire Williams, Dr Gary Stephens

The cannabinoids that this research will focus on include but are not limited to: delta-9-tetrahydrocannabinol, cannabidiol, cannabinol, cannabigerol, tetrahydrocannabivarin and cannabichromene.  Previous research into these and other cannabinoids suggest that isolated cannabinoids may have a diverse range of medical indications.  Such potential usages include prescribing certain compounds as anxiolytics, anti-depressants and sedatives. We hope to begin lab testing in June 2011 and publish results summer 2012.

Meanwhile we  are keen to hear of your experience of using cannabis therapeutically for mental health concerns or diagnosed conditions. If you are interested in contributing to this research please add a comment below.

Disclaimer: This research is essentially preliminary, all compounds are being tested on laboratory rats.  Any findings would have to be replicated in humans before they could be utilised in a medical or political decision. Please do not attempt to replicate any of our trials without Home Office approval, possession of isolated cannabinoids is regulated by the Misuse of Drugs Act 1971.

References

Increase in proportion of patients on long-term medication accounts for increase in antidepressant prescribing in UK. Evidence Based MentalHealth, 13(2):61, May 2010.

Jay C. Fournier, Robert J. DeRubeis, Steven D. Hollon, Sona Dimidjian, Jay D. Amsterdam, Richard C. Shelton, and Jan Fawcett. Antidepressant drug effects and depression severity. JAMA: The Journal of the American Medical Association, 303(1):47–53, January 2010.

Michael Moore, Ho M. Yuen, Nick Dunn, Mark A. Mullee, Joe Maskell and Tony Kendrick. Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. BMJ, 339, January 2009.

Primary Care Trust Prescribing Data: October – December 2010 (released May 2011)

Pipeline 2 Paradise Radio Hawaiian and Island Music Online



A NEW BATCH OF P2P APPAREL IS IN
FIRST COME, FIRST SERVED


Hash House A Go Go Las  Vegas


     


Flickr - projectbrainsaver

www.flickr.com
projectbrainsaver's A Point of View photoset projectbrainsaver's A Point of View photoset